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Abstract
Retinoic acid (RA), an active derivative of the liposoluble vitamin A (retinol), acts as an important signaling molecule during
embryonic development, regulating phenomenons as diverse as anterior-posterior axial patterning, forebrain and optic
vesicle development, specification of hindbrain rhombomeres, pharyngeal arches and second heart field, somitogenesis,
and differentiation of spinal cord neurons. This small molecule directly triggers gene activation by binding to nuclear
receptors (RARs), switching them from potential repressors to transcriptional activators. The repertoire of RA-regulated
genes in embryonic tissues is poorly characterized. We performed a comparative analysis of the transcriptomes of murine
wild-type and Retinaldehyde Dehydrogenase 2 null-mutant (Raldh22/2) embryos — unable to synthesize RA from maternally-
derived retinol — using Affymetrix DNA microarrays. Transcriptomic changes were analyzed in two embryonic regions:
anterior tissues including forebrain and optic vesicle, and posterior (trunk) tissues, at early stages preceding the appearance
of overt phenotypic abnormalities. Several genes expected to be downregulated under RA deficiency appeared in the
transcriptome data (e.g. Emx2, Foxg1 anteriorly, Cdx1, Hoxa1, Rarb posteriorly), whereas reverse-transcriptase-PCR and in situ
hybridization performed for additional selected genes validated the changes identified through microarray analysis.
Altogether, the affected genes belonged to numerous molecular pathways and cellular/organismal functions,
demonstrating the pleiotropic nature of RA-dependent events. In both tissue samples, genes upregulated were more
numerous than those downregulated, probably due to feedback regulatory loops. Bioinformatic analyses highlighted
groups (clusters) of genes displaying similar behaviors in mutant tissues, and biological functions most significantly affected
(e.g. mTOR, VEGF, ILK signaling in forebrain tissues; pyrimidine and purine metabolism, calcium signaling, one carbon
metabolism in posterior tissues). Overall, these data give an overview of the gene expression changes resulting from
embryonic RA deficiency, and provide new candidate genes and pathways that may help understanding retinoid-
dependent molecular events.
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Introduction
Retinoic acid (RA), an active derivative of the liposoluble
vitamin A, is an endogenous signaling molecule involved in many
biological processes in vertebrates. This small hydrophobic
compound is the ligand for a subfamily of nuclear receptors, the
retinoic acid receptors (RAR) a, b and c (NR1B1, B2 and B3), that
belong to the group of nuclear receptors heterodimerizing with
RXRs. The RAR-RXR dimers bind to DNA motifs called RA-
response elements (RAREs), typically composed of two short
similar sequences (‘‘direct repeats’’, DR) with a spacer element of
varying length (DR1, 2, 5 or 8). Although functional RAREs have
yet been characterized in a relatively small number of genes [1,2],
it is estimated that several hundred genes may harbor such
elements [3]. RAR/RXR dimers are able to bind RAREs in the
absence of ligand and – at least on some of their target promoters
–, can have a repressive function by interacting with corepressors
that silence transcription through epigenetic mechanisms (ref. [4]
for a review). RA binding leads to a conformational change in the
receptor structure, leading to a switch from a repressing to a
transcriptionally activating state. The distribution and availability
of RA in various cell populations therefore has to be tightly
controlled by enzymatic mechanisms.
Many of the known functions of RA take place during
development. As reported in several species, RA already acts
during early embryogenesis, starting at the gastrula stage [5,6].
Region-specific distributions of RA in embryonic cell populations
have been correlated with several developmental events. At early
stages, RA may act in combination with other signaling molecules
(FGF, Wnts) to provide positional identity along the prospective
embryonic anterior-posterior axis (ref. [7] for a review). Once
mesodermal segmentation (somitogenesis) is taking place, specific
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spatial RA distributions are critical for the establishment and
patterning of the hindbrain segments (the rhombomeres), whereas
more caudally, RA has been implicated in the regulation of the
symmetrical progression of somitogenesis, and in early neurogenic
events in the neural tube (the prospective spinal cord) [8,9,10,11]
(refs. [12,13,14] for reviews). Other early embryonic functions
have been reported for development of the segmented pharyngeal
apparatus (the branchial arches), and in cell populations giving rise
to the heart [15,16,17,18].
The distribution of RA among cell populations is controlled by
specific enzymatic pathways. Embryos from placental species
obtain vitamin A in the form of retinol transferred from the
maternal circulation through the embryonic yolk sac – and
eventually the placenta [19,20]. Oviparous species store retinol
and/or carotenoids in the egg yolk. Retinol reaching the embryo
can be oxidized to retinaldehyde by two classes of enzymes
(alcohol and retinol dehydrogenases: ADHs, RDHs), whereas b-
carotenoids are cleaved by b-carotene-15,159 oxygenases (BCOs)
(refs. [21,22,23,24] for reviews). Critical for the production of RA
is the presence of specific retinaldehyde dehydrogenases
(RALDHs). Three such enzymes have been characterized, all of
which being expressed according to distinct temporal and spatial
(tissue-specific) patterns during development. Interestingly, there is
a temporal window during which RALDH2 is the only RALDH to
be expressed in the early embryo, and all the functions mentioned
above have indeed been ascribed to this enzyme. This phase goes
from gastrulation to early somitic stages, during which Raldh2 gene
expression is first induced in the embryonic node and newly
formed mesoderm, and then persists at specific anterior-posterior
axial levels in several mesodermal derivatives [6,25]. Analysis of
murine Raldh22/2 null mutants harboring a RA-activatable
reporter transgene has demonstrated the absence of any detectable
RA activity throughout the embryo at these early stages [26].
Raldh2 expression is transiently seen at early somite stages (E8.0–
E8.5 in the mouse) in head tissues, including the anteriormost
neuroectoderm destined to form the anterior forebrain and optic
vesicles [27], and knockout mutation of Raldh2 affects morpho-
genesis of these structures [28,29]. The second next Raldh gene to
be expressed is Raldh3, whose transcripts first appear by E8.5 in
head structures (prospective nasal region, eye, and otocyst), and at
trunk levels in the mesonephric duct (embryonic kidney) [30,31].
Although Raldh22/2 mouse mutants have been used in a large
set of studies for unravelling the consequences of a lack of RA
signaling in early developmental processes, there is still a poor
understanding of the molecular events leading to the realization of
the RA-deficiency phenotypes. Genes abnormally expressed in the
Raldh22/2 embryos were usually identified through in situ
hybridization studies using molecular markers of the affected
structures, and there has been no attempt to globally analyze gene
expression changes at the transcriptomic level. As this mutant is a
good model for analyzing embryos developing under RA
deficiency, we decided to perform an Affymetrix DNA microarray
study to compare the transcriptomes of wild-type and Raldh22/2
embryos. We searched for gene expression changes in two regions
of the embryo: the anterior head and forebrain region, and more
posterior (‘‘trunk’’) tissues, as these correspond to two distinct –
both temporally and spatially – phases of RALDH2-dependent
RA signaling. The tissue samples were collected at such stages that
RA deficiency was installed in the corresponding region (as
documented, for instance, by the analysis of a RA-sensitive
transgene; see Fig. 1), although early enough for morphological
phenotypic abnormalities to be minimal in the mutant embryos.
The resulting data provide a global view on genes affected in their
expression by a state of embryonic RA deficiency, and highlight
possible gene networks involved in the resulting phenotypic
defects, as bioinformatic clustering analysis identified several
groups of genes displaying similar behaviors in the mutant tissue
samples. More generally, this study confirms the pleiotropic effects
of RA signaling in regulating many classes of gene products, some
of which belong to critical pathways that will help explain the
developmental consequences of a deficiency in this signal.
Results and Discussion
Experimental design
Two sets of samples were used for analyzing transcriptome
changes in Raldh22/2 embryos. The rostral part of the head
(including the anterior forebrain, optic vesicles, and overlying
tissues), was collected from wild-type and mutant embryos at the
14 somite stage. This stage was chosen according to the expression
Figure 1. Description of the samples analyzed and summary of
the microarray results. (A–D) Profile views of mouse embryos (wild-
type: A, C; Raldh22/2 mutants: B, D) at the stages chosen for analysis.
The embryos are not from the experimental series, but were collected
from litters harboring a retinoic acid-sensitive (RARE-hsp68-lacZ)
reporter transgene and processed for X-gal analysis, thereby illustrating
the absence of detectable RA activity in the mutants. The collected
samples were the anterior head region of 14 somite stage embryos (X-
gal-labelled in control embryos, section planes illustrated by arrows: A,
B) and the posterior region (X-gal-labelled in control embryos, section
plane illustrated by arrows: C, D) of 4 somite stage embryos. (E, F)
Principal component analysis illustration of ANT and POST data sets.
Wild-type samples are depicted by blue dots, and Raldh22/2 samples
by red dots. For anterior tissues, wild-type and Raldh22/2 samples
segregate in two distinct groups. In the case of posterior tissues, one
Raldh22/2 sample (#046) did not cluster with the others, and was
excluded from subsequent analyses. (G) VENN diagrams summarizing
the numbers of genes showing statistically significant different
expression levels, with a fold change of 61.2 (upper numbers) or
61.5 (lower, bold numbers). The numbers of genes exhibiting a
‘‘contradictory’’ behavior (upregulated in one type of samples, and
downregulated in the other, as pointed out by the arrows) are also
given.
doi:10.1371/journal.pone.0062274.g001
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profiles of Raldh genes in head tissues of wild-type embryos: it
shortly follows the phase of peak Raldh2 mRNA expression at 8-10
somites [27], while RALDH2 protein is still detectable [29],
whereas Raldh3 mRNA expression, first detected at the 10–12
somite stage, has not yet intensified. It is unlikely that RALDH3
significantly participates to RA synthesis in the head at the stage of
analysis, and – as described in a previous study [29] – we
confirmed by analyzing Raldh22/2 mutants carrying the RARE-
hsp68-lacZ transgene [32], that there was no detectable activity of
the lacZ reporter at the 14 somite stage (Fig. 1A, B). The tissues
collected for analysis included the optic cup and the forebrain
neuroepithelium located more rostrally (prospective telencepha-
lon), as well as the overlying tissues (frontonasal region including
the olfactory placode). These samples are referred to thereafter as
‘‘anterior’’ (ANT) tissues.
The posterior tissues were analyzed at the 4 somite stage, and
samples were collected from a transverse section plane excluding
all tissues from the level of the first branchial arch (Fig. 1C, D). At
this stage RA has numerous documented effects (see Introduction),
however Raldh22/2 embryos do not yet exhibit morphological
deficiencies (see Fig. 1D) – but they can be recognized by trained
eyes by the presence of smaller somites and an abnormally shaped
heart tube. As expected from previous work [26], there was no
detectable activity of the RARE-hsp68-lacZ transgene in the
mutant embryos at this stage (Fig. 1D). These samples will be
referred to as ‘‘posterior’’ (POST).
Microarray analysis and statistical tests
Total RNA was extracted from individual samples using the
RNAeasy micro Kit (Qiagen), and RNA quality was assessed with
a 2100 Bioanalyzer (Agilent). Samples that displayed a RNA
Integrity Number (RIN) greater than 9.0 were selected for each
condition, and 5 mutant and 5 wild-type samples for each tissue
type (ANT and POST) were processed on Affymetrix GeneChip
Mouse Gene 1.0 ST arrays. The chips were washed and stained in
the GeneChip Fluidics Station 450, and scanned with the
GeneChip Scanner 3000 7G (Affymetrix). Raw data (.CEL
Intensity files) were extracted from the scanned images using the
Affymetrix GeneChip Command Console (AGCC) version 3.1.
One of the Raldh22/2 POST samples displayed a high
background after hybridization and could not be used for analysis.
Altogether, CEL Intensity files from 5wild-type and 5Raldh22/2
ANT samples, and 5 wild-type and 4 Raldh22/2 POST samples,
were processed for statistical analysis. CEL files were analyzed with
the Partek Genomics Suite 6.5 software. After principal component
analysis (PCA), the mutant ANT samples clearly segregated from
the corresponding wild-type (WT) samples (Fig. 1E), showing
relevant transcriptional differences between both groups. Unex-
pectedly, one of the POST Raldh22/2 samples (#046) did not
cluster with the three other mutant samples (Fig. 1F). Statistical
studies were performed including or excluding this sample, in order
to calculate its impact on the differentially expressed genes. Genes
retained for further analysis had a hybridization signal value above
5 (20th percentile of all expression values) in at least one sample.
Genes were considered as differentially expressed if the false
discovery rate (FDR) from Benjamini and Hochberg test was under
0.1. Among the 35556 probe sets represented in the microarrays,
about 10% of the genes were excluded from further analysis
because of their low expression level and/or FDR above 0.1
(corresponding to a p-value above 0.05 for ANT samples, or 0.03
for POST samples).
Overview of differentially expressed genes
Using as a threshold the p-values defined above by Partek
analysis, 7177 genes were differentially expressed in wild-type vs.
mutant ANT tissue samples (3437 upregulated, 3740 downregu-
lated in mutants; p#0.05). When POST samples were analyzed by
omitting the dubious Raldh22/2 sample (#046, Fig. 1F), 4133
genes were found to be differentially expressed (1834 upregulated,
2299 downregulated in mutants; p#0.03). When analysis was
performed including sample #046, 3120 genes were significantly
upregulated (24.5% gene loss), and only 1610 genes appeared
downregulated (30% gene loss). Thus, as predicted by PCA,
inclusion of sample #046 biased the statistical tests, and data
mining was performed with this sample excluded.
In both the ANT and POST microarray experiments, the large
majority of genes were affected by fold changes (FC) lesser than 2
fold (only 104 genes with FC .2, and 30 genes with FC ,22, in
Raldh22/2 vs. wild-type ANT samples; 42 genes with FC .2 and
82 genes with FC ,22, in Raldh22/2 vs. wild-type POST
samples). VENN diagrams in Fig. 1G show gene numbers
obtained for two cut-offs at 61.2 FC (upper lines) and 61.5 FC
(lower lines, numbers in bold). The 1.2 FC cut-off yielded
comparable numbers of genes up- or downregulated in each
experiment, with lower numbers of downregulated genes.
Furthermore, there were almost 500 genes upregulated in both
the ANT and POST Raldh22/2 tissue samples, and nearly as
many genes downregulated in both Raldh22/2 tissue samples.
These lists were reduced to 102 genes up-regulated in common,
and 14 genes down-regulated in common, at 61.5 FC.
Remarkably, the numbers of ‘‘contradictory’’ genes (being
upregulated in one tissue and downregulated in the other) was
extremely low (0 and 2 contradictory genes above 1.5 FC; Fig. 1G).
Table 1 provides a list of the most severely downregulated genes,
and details on contradictory genes are provided as supplementary
online information (Table S1). A graphic illustration of the
differentially expressed genes is also shown (Fig. 2).
Down-regulated genes include known RA-dependent
genes
As RARs behave as transcriptional activators in the presence of
their ligand, down-regulation of retinoid target genes is expected
to occur in tissues deficient in RA synthesis. We analyzed the lists
of downregulated genes to see whether genes already known to be
downregulated in the Raldh2 mutant, or more generally reported
in the literature as being RA-dependent, were detected in our
microarray experiments. Several genes shown in previous studies
to be downregulated in Raldh22/2 embryos (usually using whole-
mount in situ hybridization) [6,26,33,34,35] were also found
downregulated in the POST microarray experiment. These
include Rarb, Pax6, Hoxa1 (all ,22), Meox1 (21.68), and Cdx1
(21.40). Additional RA targets were reduced in the POST
experiment, although excluded from the filtered list due to their p-
values, including Neurog2 (21.24) [36], Olig2 (21.78) and Tbx5
(21.33) [18]. Stra6, encoding a membrane protein interacting with
retinol-binding protein (RBP) and originally characterized as a
RA-induced gene in P19 embryonal carcinoma cells [37,38] and
Dhrs3 (also known as RetSDR1), encoding a retinaldehyde
dehydrogenase/reductase, were both reduced in the caudal
region. Downregulation of Dhrs3 may be due to a feedback
mechanism caused by retinaldehyde accumulation in embryonic
tissues [39]. The Crabp2 gene (encoding cellular RA-binding
protein-II) was downregulated in both posterior and anterior
tissues, indicating that the retinoic acid-response elements
(RAREs) identified in the Crabp2 gene promoter [40] are
functional targets. The Nkx3-1 and Nkx3-2 genes were both
Transcriptome of Retinoic Acid-Deficient Embryos
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reduced in posterior tissue samples. Nkx3-1 is a RA-inducible
target in prostate cancer cells [41].
Several genes previously shown be reduced in the forebrain of
Raldh22/2 embryos [29] were also downregulated in our ANT
microarray data, for instance Dll1 (21.31), Foxg1 (21.42) and
Emx2 (21.56). Thus, a good overall correlation between our
transcriptomic data and previous analyses of Raldh22/2 embryos
(typically by non quantitative in situ hybridization) confirms the
validity and reproducibility of these studies.
Microarray analysis provides new candidate genes for the
RA-deficiency phenotypes
When considering the list of genes exhibiting the highest
changes in expression levels in Raldh22/2 embryos (Table 1), some
interesting candidates emerged as being potentially involved in the
RA-deficiency phenotype. The most highly downregulated genes
in anterior tissues encode Id4 (inhibitor of DNA binding 4), a
regulator of neural stem cell proliferation and differentiation [42],
the signal transducer and activator of transcription Stat4, and the
TBP associated factor Taf9b. Among the most severely downreg-
ulated genes are also the Ephrin receptor gene Epha3, the
neuropilin/tolloid-like gene Neto2, and the gene encoding fatty
acid-binding protein 7 (Fabp7 or brain-type Fabp). The Nr2e1
gene, encoding the orphan nuclear receptor Tlx, was also strongly
downregulated in anterior tissues. A previous study pointed to Tlx
as being involved in the regulation of the Rarb gene in the eye [43].
The SRY-box genes Sox1 (21.66) and, to a lesser extent, Sox3
(21.26), were also downregulated according to the ANT
microarray experiment.
Retinoids orchestrate the differentiation and patterning of the
posterior neural tube (the developing spinal cord) [7,13],
accompanied by induction of a posterior transcriptional signature
previously analyzed in the spinal cord at an early fetal stage [44].
Our analysis of posterior embryonic tissues (see Table 1)
confirmed many known caudal neuronal targets, including Pax6,
Hoxa1, Dbx1, a homeobox gene involved in spinal cord interneu-
ron specification [45] and Lhx1, a LIM-homeodomain protein
regulating gastrulation, renal organogenesis, and other embryonic
functions [46]. Of note, the Lhx1 homologue Lhx2 was downreg-
ulated in both ANT (21.60) and POST (21.45) tissues. Novel
downregulated genes included Sfrp5, encoding a secreted antag-
onist of Wnt signaling [47], and Nepn (Nephrocan), encoding an
inhibitor of TGFb signaling [48]. Other significant reduced targets
include Dmrt2 (doublesex and mab-3 related transcription factor
2), involved in somitogenesis and early myogenesis [49], Myf5 (a
regulator of early myocytic lineage decisions), Metrn (encoding
Meteorin, a secreted protein controlling neuritogenesis and
angiogenesis in glial precursors [50]), Unc5a (encoding a Netrin
receptor involved in spinal cord development [51]), Tcf15
(encoding the basic helix-loop-helix protein Paraxis involved in
presomitic mesoderm differentiation [52]), and Rfx6 (encoding a
winged helix transcription factor required for pancreatic develop-
ment [53]).
While a deficiency in embryonic RA should primarily result in
lack of activation of RA/RAR inducible genes, feedback
mechanisms may lead to upregulation of genes which may also
be relevant for the resulting phenotypes. Among the highest
upregulated genes were two genes coding for basic helix-loop-helix
proteins, Bhlhe40 and Bhlhe41 – also known as Sharp2 and Sharp1
[54]. Bhlhe40 was first reported under the name of Stra13, as a RA-
inducible gene promoting neuronal differentiation in P19 cells
[55]. It was therefore unexpected to see it upregulated in vivo in
Raldh22/2 embryonic tissues. For this reason we included Bhlhe40
among the set of genes for which additional analyses (quantitative
RT-PCR and in situ hybridization) were performed to confirm the
expression changes (see below). Other transcription factor-coding
genes were upregulated in Raldh22/2 samples, namely the Hairy/
Enhancer-of-Split-related gene Hey2, the winged-helix protein-
coding gene FoxO3, the zinc finger protein-coding gene Egr1
(formerly known as Krox24), and the orphan nuclear receptor
RORa gene (Rora). Other upregulated genes included the Rras
proto-oncogene coding for the R-Ras GTPase, the Ccng2 gene
coding for cyclin G2 – which is regulated at the mRNA level by
FoxO3 [56], and the Vldlr (very low density lipoprotein receptor)
gene, the latter protein also acting as a Reelin receptor during
development [57]. Genes encoding ligands or modulators of
specific signaling pathways (e.g. Efna3, Fgf11, Igfbp1, Vegfa) were
also present in the list. A detailed analysis of the main genetic and
Figure 2. Volcano plots representing corrected p-values (ordinates,2log10 scale) from Student t-test of the mRNA levels compared
in wild-type and Raldh22/2 samples anterior (A) and posterior (B) embryonic tissue samples. Genes with a fold change (abscissae) higher
than 1.5 and a false discovery rate lower than 0.1 are shown in red.
doi:10.1371/journal.pone.0062274.g002
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Table 1. Most severely downregulated genes in Raldh22/2 tissue samples.
DOWN in ANTERIOR TISSUES (1)
Symbol Name Function
Id4 Inhibitor of DNA binding 4 Regulation of transcription and cell proliferation, brain, hippocampus
development
Stat4 Signal transducer and activator of transcription 4 Regulation of transcription and cell proliferation, signal transduction
Taf9b Taf9b, TBP-associated factor Regulation of transcription
Mfsd2 Major facilitator superfamily domain containing 7B Unknown
Car3 Carbonic anhydrase 3 Lyase activity
Epha3 Eph receptor A3 Transmembrane receptor, protein kinase
Rhag Rhesus blood group-associated A glycoprotein Ammonium transmembrane transporter
Syt11 Synaptotagmin XI Calcium transmembrane transporter
Ptprz1 Protein tyrosine phosphatase, receptor type Z,
polypeptide 1
Axonogenesis
Cpa2 Carboxypeptidase A2 Metallocarboxypeptidase
Neto2 Neuropilin (NRP) and tolloid (TLL)-like 2 Membrane receptor
Gm9983 Predicted gene 9983 Unknown
Mfsd7b Major facilitator superfamily domain containing 7B Head, digits, and spleen development
Fabp7 Fatty acid binding protein 7, brain Lipid transport, forebrain neurogenesis
Slfn9 Schlafen 9 Unknown
Jakmip2 Janus kinase and microtubule interacting protein 2 Kinase, microtubule interacting protein
Slc4a1 Solute carrier family 4 (anion exchanger), member 1 Anion exchanger transport
Nr2e1 Nuclear receptor 2E1 (Tlx) Regulation of transcription, brain and eye development
Idi1 Isopentenyl-diphosphate delta isomerase Steroid and carotenoid biosynthesis
Lonrf2 LON peptidase N-terminal domain and ring finger 2 Unknown
DOWN in POSTERIOR TISSUES (2)
Symbol Name Function
Arg1 Arginase Arginase activity
1700011H14Rik Unknown Unknown
Rarb Retinoic acid receptor beta Transcriptional regulation, embryogenesis, neurogenesis
Nepn Nephrocan Negative regulation of transcription and of TGFb receptor signaling
Hnf1b HNF1 homeobox B Regulation of transcription, inner cell mass differentiation, anterior-posterior
patterning, hindbrain development
Dbx1 Developing brain homeobox 1 Regulation of transcription, spinal cord interneuron specification
Rfx6 Regulatory factor X, 6 Regulation of transcription, pancreatic development
Pax6 Paired box gene 6 Regulation of transcription, brain, eye, spinal cord development,
neurogenesis
Hoxa1 Homeobox gene A1 Regulation of transcription, hindbrain development, anterior-posterior
patterning, inner ear morphogenesis
Nxf3 Nuclear RNA export factor 3 mRNA export
Gm10785 Unknown Unknown
Unc5a Unc-5 (C. elegans) homolog A Membrane receptor, apoptosis, signal transduction
Maob Monoamine oxidase B Oxidoreductase
Lhx1 LIM homeobox protein 1 Regulation of transcription, ectoderm/endoderm formation, pattern
specification, nervous system and urogenital development
Slc16a12 Solute carrier family 16 (monocarboxylic
acid transporters), member 12
Symporter activity
Olig2 Oligodendrocyte transcription factor 2 Regulation of transcription, oligodendrocyte specification
Fgfr4 Fibroblast growth factor receptor 4 Membrane receptor, tyrosine kinase
Sfrp5 Secreted frizzled-related sequence protein 5 Extracellular modulator of Wnt signaling, foregut endoderm and mesoderm
development
Cpa1 Carboxypeptidase A1 Metallopeptidase, proteolysis
Dhrs3 Dehydrogenase/reductase (SDR family) 3 Oxidoreductase
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regulatory pathways emerging from the transcriptomic analysis of
RA-deficient embryos is presented below.
Retinoid targets regulating stem cell lineages
Our transcriptomic analysis has uncovered some novel RA
targets regulating neuronal stem cell lineages, and whose
deficiency might explain forebrain abnormalities in Raldh22/2
embryos. Id4, Tlx, and Sox1 are all reduced in ANT Raldh22/2
tissues. The mutant embryos exhibit dramatic reductions in
telencephalon neuroepithelium growth, a defect previously pro-
posed to be due to reduced fibroblast growth factor (FGF) and
Sonic hedgehog signaling [29]. Retinoid regulation of gene targets
in stem cells could also stunt cerebral growth. Interestingly, Id4
regulates lateral expansion of the proliferative zone in the
developing cortex [42] by facilitating self-renewal and proliferation
of neural stem cells [58]. Tlx maintains neural stem cells in an
undifferentiated, proliferative state [59], whereas Sox1-expression
marks activated neural progenitors. Sox1 also functions to
maintain cortical progenitors in an undifferentiated state by
suppressing cell cycle exit to neurogenesis [60]. Collectively, Id4,
Tlx, and Sox1 reductions may be sufficient to affect forebrain
development by hindering neural stem cell growth. Neural stem
cells may consequently undergo premature differentiation, ex-
plaining why we observe increased levels of Sox10 [29] and Bhlhe40
in Raldh22/2 forebrains. Reduced FGF signaling and cyclin D
levels [29] could be a consequence, and not the cause, of reduced
progenitor growth. In another study we have shown that Raldh2
loss of function reduces expansion and differentiation fetal spinal
cord-derived neural stem cells [44]. Our ongoing work using
neurosphere assays indicates that neural stem cells are similarly
affected in the forebrain of 14 somite-stage Raldh22/2 embryos
(M.P. et al, unpublished data).
Retinoic acid is commonly used as an inducer of neuronal
differentiation in various tissue culture cell lines. Remarkably,
retinoids can differentiate embryonic stem (ES) cell-derived
embryoid bodies to a relatively pure stem cell lineage known as
radial glia [61]. Radial glial cells are found at the earliest stages of
CNS development and play an important role in cortical
expansion. An in vivo role of retinoids in promoting this lineage,
though, has never been shown. Two players in the radial glia
lineage, Pax6 and Fabp7, are both reduced in ANT Raldh22/2
tissues. Pax6 maintains the proliferative capacity and develop-
mental potential of radial glia stem cells [62], whereas Fabp7 (also
known as Brain Lipid Binding Protein, BLBP) is a structural
marker also required for the establishment of the radial glia fiber
system in the developing brain [63].
Clustering analysis of gene expression changes in
Raldh22/2 embryos
To obtain a more global view of the gene expression changes
detected in the Raldh22/2 embryos, we performed clustering
analysis using the Cluster 3 software [64]. An overview of the
entire clustering analysis is provided as online supporting
information in the form of a heat map (Figure S1), and selected
gene clusters are shown in Figure 3. A green-to-red scale (Fig. 3,
bottom) illustrates the gene expression changes between samples,
from lowest (bright green) to highest (bright red) relative levels.
The clustering analysis further validated our experimental
samples, as WT and mutant (KO) samples segregated into distinct
clusters, with no co-segregation of any WT and KO sample
(Fig. 3A).
Table 1. Cont.
DOWN in ANTERIOR and POSTERIOR TISSUES (3)
Symbol Name Function
DOWN in ANTERIOR and POSTERIOR TISSUES (3)
Symbol Name Function
Apba2 Amyloid beta (A4) precursor protein-binding, family A,
member 2
Neuronal adaptor protein, synaptic transmission
Ap1s3 Adaptor-related protein complex AP-1, sigma 3 Intracellular protein transport, endocytosis
Ccnb1ip1 Cyclin B1 interacting protein 1 Blastocyst formation, organ growth, meiosis and spermatid development,
apoptosis
Ccne1 Cyclin E1 Cyclin-dependent protein kinase, cell cycle control
Csn3 Casein kappa Oocyte meiosis, lactation
Elovl2 Elongation of very long fatty acids-like 2 Lipid biosynthesis
Kbtbd8 Kelch repeat and BTB (POZ) domain containing 8 Unknown
Pmm2 Phosphomannomutase 2 Mannose biosynthesis
Ptprz1 Protein tyrosine phosphatase, receptor type Z Extracellular matrix protein, hydrolase, neuritogenesis
Rrp12 Ribosomal RNA processing 12 (S. cerevisiae) homolog Unknown
Snhg1 Small nucleolar RNA host gene Unknown
Tmem56 Transmembrane protein 56 Unknown
Trmt61a tRNA methyltransferase 61 homolog A tRNA methyltransferase activity
Pinx1 (2610028A01Rik) PIN2/TERF1 interacting, telomerase inhibitor 1 Telomere maintenance, nucleic acid and protein binding
(1)Genes listed by decreasing fold change in expression, ranging from 23.3 to 21.9.
(2)Genes listed by decreasing fold change in expression, ranging from 24.5 to 21.7.
(3)Genes listed alphabetically, fold change in expression ,21.5 in both the ANT and POST microarrays.
The table distinguishes the ‘‘top’’ downregulated genes in anterior or posterior tissues, and the genes affected in both types of samples.
doi:10.1371/journal.pone.0062274.t001
Transcriptome of Retinoic Acid-Deficient Embryos
PLOS ONE | www.plosone.org 6 April 2013 | Volume 8 | Issue 4 | e62274
Such analysis allows us to pinpoint genes exhibiting similar
behaviors (in terms of variation in expression levels) among the
analyzed samples. As a first example, the Id4 and protocadherin 19
(Pcdh19) genes clustered with Six2, being selectively downregulated
in anterior tissue samples (Fig. 3B). Interestingly also, the Foxg1
and Emx2 genes – both described as downregulated in the
forebrain of Raldh22/2 embryos [29] – were found in the same
cluster (Fig. 3C). This cluster also included a Wnt gene (Wnt7b),
the LIM/homeobox gene Lhx2, and the nuclear receptor gene
Nr2e1. Another interesting cluster contained the Pax6 and Crabp2
genes (Fig. 3D). Unlike the former ones, genes from this cluster
were downregulated in both anterior and posterior Raldh22/2
tissues samples, while their expression levels were higher in
anterior tissues (both in WT and KO situations). Such a behavior
is not surprising, as Pax6 and Crabp2 are highly expressed in most
of the tissue (forebrain and optic vesicle) constituting the ANT
samples. The cluster also included Sall2 (a drosophila Spalt
homologue), Unc119b, Mkrn3 (Makorin), and Metrn (Meteorin).
Another cluster grouped the Msx2 homeobox gene, a Snail
homologue (Snai2), a Dickkopf homologue (Dkk3), an Ikaros family
gene (Ikzf4), and the Map kinase gene Map4k2, all being relatively
mildly downregulated in ANT samples (Fig. 3F).
Genes from the cluster containing Foxo3 and the IGF receptor
gene Igf1r, on the other hand, were upregulated in both the ANT
Figure 4. Microarray validation by quantitative real-time RT-
PCR (Q-PCR). Genes were selected according to their different
expression profiles as detected by microarray analysis of wild-type
(WT) and Raldh22/2 embryos. Among these, one gene (Pax6) was
chosen as a ‘‘control’’, as its expression had already been shown to be
affected in Raldh22/2 embryos (see main text for details and
interpretation of the data). Expression levels are expressed as values
normalized with respect to Gapdh (a housekeeping gene) mRNA levels
(WT samples, blue bars; Raldh22/2 samples, red bars). Data (mean 6
SEM) were analyzed with Student t-test; ***, p,0.001; **, p,0.01; *,
p,0.05.
doi:10.1371/journal.pone.0062274.g004
Figure 3. Details of the gene expression profiles obtained after
hierarchical clustering of the experimental samples by relative
gene expression level analysis. Eight clusters (panels B–I) have
been extracted from the overall clustering analysis (available as
additional online information, Figure S1), showing differential gene
expression behaviors according to the experimental samples (ANT, RNA
from anterior tissues; POST, RNA from posterior tissues; WT, wild-type
embryos; KO, Raldh22/2 embryos). Gene expression profiles are
illustrated as a heat map (green: weak expression; red: strong
expression – see scale below). The expression profile of the Rarb gene
is also shown (panel J), which did not cluster with any other gene. This
analysis further validated the experimental samples, as WT and KO
samples segregated into fully distinct clusters, both for the ANT and
POST tissue samples (panel A above).
doi:10.1371/journal.pone.0062274.g003
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and POST Raldh22/2 samples, although globally they were
expressed at higher levels posteriorly (Fig. 3G). This 14 gene
cluster also contained the chordin-like gene Crim1, the latent
TGFb-binding protein gene Ltbp1, the zinc finger protein genes
Zkscan2 and Zmym6, as well as 3 unannotated Riken gene
transcripts.
Two examples of genes exhibiting selective downregulation in
the POST Raldh22/2 tissue samples are shown. In the first one,
the RARE-containing gene Cdx1 clusters with Lhx1, Sfrp5, the
nephrocan (Nepn) gene, and the gene encoding the FGF pathway
inhibitor Sprouty3 (Spry3) (Fig. 3H). The second one includes Gli1,
encoding a transcriptional effector of Hedgehog signaling shown
to be downregulated in Raldh22/2 embryos [6]. This gene clusters
with Stra6 and several other potentially interesting genes, including
two NKx genes (NKx2-2 and 2-9), the Frizzled homologue Fzd4,
the forkhead protein-coding gene Foxp4, Ripply3 (encoding a Tbx1
repressor), and Unc5a (encoding a Netrin receptor).
Finally, the gene encoding RARb (Rarb), a direct RA-inducible
gene containing a functional RARE [65] was not included in any
gene cluster (Fig. 3J). This behavior could be linked to its weak
expression in all anterior tissue samples, whereas downregulation
was clearly seen in posterior samples.
Selected gene analysis by quantitative RT-PCR and in situ
hybridization
Some genes were selected to perform real-time quantitative
reverse transcriptase-PCR (Q-PCR) analysis in order to validate
the changes detected by the microarray experiments. We focused
on Pax6, expected to be downregulated both in anterior and
posterior tissues of Raldh22/2 embryos, Id4, Six2 and Stat4 as
examples of genes identified by microarray analysis as being
downregulated anteriorly, and Lhx2, Crabp2, Ikzf1 and Unc5a, that
were scored as being downregulated in both regions of the mutant
embryos. We also sought to confirm the upregulation of certain
genes identified by microarray analysis, mainly for Bhlhe40 (Stra13)
which, as discussed above, was not expected to be upregulated in
the RA-deficient embryos. Creb5 (encoding a cAMP-responsive
element binding protein) was chosen as an example of a gene with
different behavior in anterior (slightly downregulated) versus
posterior (upregulated) tissues.
Overall, the Q-PCR experiments showed a clear correlation
with the changes observed by microarray analysis (Fig. 4). Of note,
the Id4 and Six2 genes, that were scored as downregulated
anteriorly in the microarray experiments, were also shown to be
downregulated in posterior tissues by Q-PCR analysis, although
with a lesser fold change than in anterior tissues. This could be
explained by the higher sensitivity of the Q-PCR technique. The
same observation was made for Stat4, which was downregulated
posteriorly – to a lesser extent than in anterior tissues – according
to Q-PCR analysis, whereas microarray analysis only revealed an
anterior downregulation. In agreement with the microarray data,
the Bhlhe40 gene was markedly upregulated, both in anterior and
posterior tissues, according to Q-PCR results. Whereas Q-PCR
showed a downregulation of Creb5 in anterior tissues of Raldh22/2
embryos, there was no significant change in transcript levels in
posterior tissues.
Thus, for the selected genes the Q-PCR analysis tended to
validate the microarray data. In particular, all genes that were
scored as downregulated in the microarray analysis were
confirmed by Q-PCR, the latter method often revealing a
downregulation in the two types of tissue samples – while
microarrays sometimes showed a change only in one type of
samples. This points to some limitations in the sensitivity of DNA
microarrays, implying that some genes identified as mildly
downregulated could in fact be more severely affected in the
mutant embryos.
We further attempted to document changes in expression by
another technique, in situ hybridization (ISH). These experiments
confirmed alterations in transcript levels and/or tissue distribution
for some of the genes studied. Consistent with previous reports
[29,34], Pax6 was downregulated in the caudal neural plate, as
well as in more anterior regions of the developing neuroepithe-
lium, including the forebrain, in early somite stage (E8.5)
Raldh22/2 embryos (Fig. 5A). Lhx2 was downregulated in the
forebrain of Raldh22/2 embryos, and was undetectable in
posterior tissues expressing the gene in control embryos (Fig. 5B).
An overall decrease of the Six2 ISH signal was observed in
Figure 5. Validation of gene expression changes in Raldh22/2 embryos by in situ hybridization (ISH). A subset of the genes analyzed by
Q-PCR yielded detectable signals when performing ISH with antisense riboprobes. Although less sensitive than Q-PCR, this technique allows to
analyze mRNA tissue distributions. See main text for an interpretation of the data. Embryos are shown at the 4–6 somite stage for Pax6 (A: upper
panels, ventral views; lower panels, dorsal views), Lhx2 (B: central panels) and Six2 (C: upper panels, profile views; lower panels, dorsal views), E9.5 for
Lhx2 (B: upper panels, profile views; lower panels, forebrain frontal views), 6–7 somite stage (upper panels) and early limb bud (lower panels) stages
for Crabp2 (D), 6 somite stage (upper views) and E9.5 (lower views) for Bhlhe40 (E). WT: wild-type embryos; 2/2: Raldh22/2 embryos.
doi:10.1371/journal.pone.0062274.g005
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Raldh22/2 embryos (Fig. 5C). Crabp2 was downregulated along the
developing neural tube and caudal neural plate in early somite
stage mutants (Fig. 5D, upper panels), and at later stages was also
undetectable in neural crest-derived branchial arches cell popu-
lations (Fig. 5D, lower panels). Remarkably, Bhlhe40 upregulation
was also documented in Raldh22/2 embryos by ISH. At early
somite stages, higher expression was detected in the hindbrain
rhombomeres and extended ectopically along the neural tube
(Fig. 5E, upper panels), whereas at later stages an abnormally high
expression was observed in most regions of the embryo (Fig. 5E,
lower panels). ISH experiments performed with Id4, Stat4, Ikzf1 or
Unc5a probes did not yield any consistent signal, either in wild-type
or in Raldh22/2 embryos.
In summary, the changes detected by microarray analysis were
for the most part confirmed by Q-PCR for selected genes, and
could be documented at the tissue level for some of the genes by
ISH. The latter technique has a limited sensitivity, as mRNA
detection does not use an amplification step like in RT-PCR, and
its readout is qualitative rather than quantitative. It is therefore not
unexpected that some gene expression changes documented by
transcriptome analysis and Q-PCR may not be visualized through
ISH.
Bioinformatic analysis of the transcriptomic data
To get further insight into the cellular functions and classes of
molecules that may be affected by RA deficiency, we performed an
overall analysis of the transcriptome alterations using the Ingenuity
Pathway Analysis (IPA) software. Figure 6 gives an overview of the
main biological functions (with the more significant and therefore
low p-values according to Ingenuity analysis) associated with the
transcriptome of Raldh22/2 embryos. These functions are clearly
relevant as they relate to general developmental processes (Cellular
Development, Embryonic Development, Organ Development), or
more specific phenomenons for which retinoid signaling has
already been implicated (Cardiovascular System Development,
Skeletal and Muscular System Development for the POST
microarray experiment). Inclusion of more basic biological
functions (Cell-to-Cell Signaling and Interaction, Cellular Move-
ment, Cellular Growth and Proliferation), as well as disease-related
categories (Cancer, Neurological Disease, Genetic Disorder,
Reproductive System Disease) are also not surprising considering
the known effects of retinoids on cell growth and their use in
clinical trials for chemotherapy or prevention of certain cancers
[66]. These observations prompted us to further analyze the types
Figure 6. Overview of the main biological and physiological functions correlating with the affected genes in Raldh22/2 embryos. The
functions are listed by decreasing order of statistical significance [2log(p-values)] of differentially expressed and misregulated genes as calculated by
the Ingenuity software. Left side (black bars): ANT microarray data; right side (gray bars): POST microarray data.
doi:10.1371/journal.pone.0062274.g006
Figure 7. Main classes of molecules downregulated in Raldh22/2 embryonic tissues, according to Ingenuity pathway analysis of the
transcriptomic data. Pie charts illustrate the distribution of gene products according to subcellular location (A) or protein function (B), when
considering the overall set of affected genes (fold change 61.2, filtered for FDR ,10% and a p-value #0.03 for POST and #0.05 for ANT).
doi:10.1371/journal.pone.0062274.g007
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of molecules and the molecular pathways affected by embryonic
RA deficiency.
When the transcriptome data were sorted according to the
subcellular localization of the corresponding proteins, there was an
over-representation of nuclear proteins (mainly at the expense of
cytoplasmic proteins) among genes affected in the POST
microarray experiment (Fig. 7A). All major classes of molecules
were represented among the sets of affected genes, both for the
ANT and POST experiments (Fig. 7B). Notably, there was an
over-representation of transcriptional regulators among affected
genes in the POST experiment, whereas translational regulators
were under-represented when compared to the ANT data set. A
list of genes/proteins involved in transcriptional regulation and
identified as down-regulated in the ANT and POST microarray
experiments is provided as supplementary online information
(Table S2).
Molecular pathways affected in Raldh22/2 embryos
Alteration of retinoic acid signaling has already been shown to
interfere with several signaling pathways within the embryo (refs.
[22,67,68] for reviews). Often the changes were described as
changes in expression levels of ligands, such as FGFs [8,9], Wnts
[69] or TGFb [70]. In the case of the Sonic hedgehog (Shh)
pathway, no change in ligand expression was observed in head or
posterior embryonic tissues of Raldh22/2 mutant embryos,
although expression of effectors of this pathway was altered
[6,29]. Analysis of the transcriptomic data provides a more global
overview of the molecular pathways that may be affected under
conditions of embryonic RA deficiency. A graphic summary of the
main pathways identified by Ingenuity analysis is provided in
Figure 8. The molecular pathways are listed by decreasing order of
statistical significance as they appear through analysis of the ANT
(left-side list) and POST (right-side list) data sets. The six ‘‘top’’
(most significant) pathways for each data set are highlighted in
gray, and additional pathways relevant for development are also
illustrated. The numbers of genes downregulated (green bars) or
upregulated (red bars) are illustrated (upper bars: ANT transcrip-
tomic data; lower bars: POST transcriptomic data).
As observed through the analysis of biological functions, several
‘‘top’’ pathways emerging from the ANT microarray data are
related to nervous system development or function (axonal
guidance, Reelin signaling, Notch signaling, synaptic long term
potentiation, dopamine receptor signaling). Although some of
these phenomenons take place at later developmental stages than
those analyzed, their presence in the top list is easily explained as
they contain genes also acting during early embryogenesis. The
main molecular pathways identified by the analysis of POST
microarray data are more varied, encompassing categories with
large numbers of molecules (pyrimidine metabolism, purine
metabolism, protein ubiquitination), and more specific pathways
with a highly significant p-value, but with much fewer misregu-
lated genes. For instance, the ‘‘role of Oct4 in pluripotency’’
pathway appeared among the top pathways with only 5
downregulated genes (Foxa1, Foxd3, Hoxb1, prohibitin Phb, and
Polycomb group ring finger Pcgf6). The ‘‘calcium signalling’’
pathway was characterized by the presence of 24 upregulated (vs.
1 downregulated) genes, including those encoding alpha 1 (skeletal
muscle) actin (Acta1), cardiac myosin light chain 3 (Myl3) and
heavy chain 7 (Myh7), calcium/calmodulin-dependent protein
kinase IG (Camk1g), Creb5, Nfatc4, Nfat5, and the histone
deacetylase genes Hdac5 and Hdac8. Inclusion of the ‘‘one carbon
(folate) metabolism’’ pathway among the most significantly
affected ones may reveal a novel retinoid function, so far poorly
studied, although some evidence for a regulation of this pathway
by retinoids emerges from metabolomic studies in embryonic stem
cells (L.J. Gudas, personal communication). The downregulated
Figure 8. Summary diagram of the major molecular pathways emerging from Ingenuity analysis of the Raldh22/2 transcriptome. The
molecular pathways are listed by decreasing order of statistical significance as they appear through analysis of the ANTERIOR (left-side list) and
POSTERIOR (right-side list) data sets. The most significant pathways identified for each data set are highlighted in gray. Additional pathways relevant
for developmental processes are also listed. A graphic representation of the numbers of genes downregulated (green) or upregulated (red) in anterior
(upper bars) or posterior (lower bars) Raldh22/2 embryonic tissue samples (fold change 61.2, filtered for FDR ,10%) is shown. The total number of
genes comprising each pathway (middle line, gray shaded), and the percentages of genes misregulated in each experiment, are also given.
doi:10.1371/journal.pone.0062274.g008
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genes include Dhfr (dihydrofolate reductase) and Mthf1 (methylene
tetrahydrofolate dehydrogenase). Furthermore, the folate receptor-
coding gene Folr1 was markedly downregulated (22.35), although
with a p-value .0.05. Another potentially interesting pathway is
that relating to CHK proteins in cell cycle control, which
contained 7 downregulated genes, including Cdc25a, genes coding
for E2F transcription factors 3 and 4 (E2f3, E2f4), Replication
factor C3 (Rpc3), and Replication protein A1 (Rpa1).
Many of the signaling pathways acting during early embryo-
genesis appeared with a high significance value in the bioinfor-
matic analysis of the transcriptomic data. This supports the idea of
complex RA-dependent regulatory events, and ‘‘cross-talks’’
between the retinoid and other embryonic signaling pathways.
Table 2. Genes acting in selected signaling pathways and misregulated in Raldh22/2 tissue samples (ANT: anterior samples; POST:
posterior samples).
PATHWAY ANT ANT POST POST
Upregulated Downregulated Upregulated Downregulated
FGF Ligands Fgf10, Fgf11, Fgf16 Fgf13, Fgf17 Fgf10, Fgf11
Receptors Fgfr2 Fgfr4
Effectors Akt3, Gab1, Map2k1, Map2k6,
Map3k1, Mapk3, Mapk13, Met,
Plcg1, Rac3
Hras, Mapk11, Pik3c2B,
Pik3cb, Pik3r3
Akt3, Frs2, Map3k1,
Creb5
Mapk13, Hras
BMP Ligands Bmp2, Bmp4 Bmp2, Bmp4, Bmp5
Receptors Bmpr1b Bmpr2 Bmpr1b
Effectors/Modulators Id1, Fst, Fstl3,
Gpc3, Grem1, Htra1, Map2k1,
Mapk3, Mapk13, Msx2, Pitx1,
Pitx2, Rras, Smad7
Ecsit, Hras, Mapk10,
Mapk11, Mras, Prkag1,
Prkag2, Prkar1b
Mapk10, Msx2,
Pitx1, Pitx2, Prkar1b,
Rras, Smad7
Hras, Mapk13
TGFb Ligands Inha, Tgfb1 Inha, Tgfb1, Tgfb2,
Receptors Acvr2a, Ptgfr, Tgfbr2, Tgfbr3 Tgfbr2, Tgfbr3
Effectors/Modulators Ltbp1, Map2k1, Map4k1, Mapk3,
Rras, Smad6, Smad7, Tgfb1i1,
Tgfbi, Tgif1
Foxh1, Hras, Mras, Stat1 Eng, Ltbp1, Rras,
Serpine1, Smad7,
Tgfbi, Thbs1
Foxh1, Hras, Tgfbrap1
Hedgehog Ligands Ihh
Receptors Ptch1 Ptch2
Effectors Dyrk1b, Prkar1b, Hhip Prkag2 Prkar1b, Dyrk1b Gli1
IGF Ligands Ctgf, Cyr61
Receptors Igf1r Igf1r
Effectors/Modulators Akt3, Igfbp2,
Igfbp3, Igfbp4, Igfbp5, Irs1,
Foxo3, Grb10, Map2k1, Mapk3,
Prkar1b, Rac3, Rras, Shc1
Hras, Pik3c2B, Pik3cb,
Pik3r3, Prkag1, Prkag2
Akt3, Foxo3,
Igfbp2, Igfbp3,
Igfbp5, Prkar1b, Rras,
Shc1
Hras
VEGF Ligands Figf, Pgf, Vegfa, Vegfb, Vegfc Pgf, Vegfa, Vegfc
Receptors Flt1, Flt4 Flt1
Effectors/Modulators Actc1, Actg2,
Actn3, Akt3, Foxo3, Map2k1,
Mapk3, Plcg1, Rac3, Rras, Shc1
Eifay, Eif2b1, Eif2b4,
Hif1a, Hras, Mras,
Pik3c2B, Pik3cb, Pik3r3
Acta1, Actn2, Akt3,
Foxo3, Kdr, Rras,
Shc1
Eif2b1, Eif2b4, Eif2s2, Hras
Wnt Ligands Wnt1, Wnt7a, Wnt7b Wnt2, Wnt4, Wnt5a Wnt7a
Receptors Acvr2a, Cd44, Fzd5, Fzd7 Fzd9, Ldlr Cd44, Frzb, Ldlr Fzd4,
Effectors/Modulators Aes, Akt3, Cdh1, Cdh5, Dact1,
Dkk1, Dkk3, Sostdc1, Calcoco1,
Hbp1, Kremen1, Lrp1, Lrp5, Mitf,
Porcn, Pp2r5c, Ppp2r3a, Ppp2r5c,
Prkcd, Rac3, Ror2
Apc2, Celsr2, Ndp,
Ppp2r1b,
Ppp2r2c,
Akt3, Calcoco1,
Cdh3, Dakt1, Dkk1,
Dkk2, Gnao1, Hbp1,
Lrp1, Mitf, Ppp2r3a,
Rspo1, Rspo3,
Sostdc1, Tcf3, Wisp1
Hnf1a, Lect2, Ndp, Ppp2r1b,
Sfrp5
Retinoic acid Synthesis enzymes Aldh1a2,
Aldh1a3, Aldh1a7
Rdh10 Adh1
Metabolism enzymes Cyp26c1 Cyp26b1
Receptors Rara, Rarg Rarg Rarb
Effectors/Modulators Cited2, Ncoa1, Nr2f1
(Coup-Tf1), Nr2f2 (Coup-Tf2),
Pnrc1, Vegfa
Crabp2, Gdap1, Gdap2 Ncoa1, Pnrc1,
Rarres2, Smarca2,
Vegfa
Crabp2, Raet1d, Rbp1,
Rbp4, Stra6, Triml2, Ttr
Key: Bold indicates a fold change exceeding 61.5.
Italics indicate a p-value .0.05 (ANT) or .0.03 (POST).
doi:10.1371/journal.pone.0062274.t002
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Interestingly, among the top (most significant) pathways listed for
the ANT transcriptomic data, two were not the major candidates
that would be predicted from the literature: VEGF signaling and
ILK signaling. Three Vegf genes (Vegfa, Vegfb, Vegfc), as well as the
Platelet-derived growth factor C (Pdgfc) and Placental growth
factor (Pgf) genes, appeared among the genes upregulated in both
pathways (see Table 2 for a full list of misregulated genes in the
VEGF signaling pathway). CDK5 and JAK/Stat signaling were
also among the highest significant pathways in ANT tissues. Most
affected genes in this category also appear as effectors in other
pathways (see Table S2 for details). It is noteworthy to mention
Stat4 as markedly downregulated (23.07), Stat1 more mildly
downregulated (21.24), and Stat2, Stat5b and Stat6 upregulated in
ANT tissues of mutants.
Table 2 gives details on genes misregulated belonging to several
major embryonic signaling pathways (FGF, BMP, TGFb, Hedge-
hog, IGF, Wnt/beta-catenin, and the retinoid pathway itself). In
most cases the affected genes encoded for a subset of the ligands,
more exceptionally a receptor (Fgfr2 upregulated in ANT tissues,
Bmpr1b and Bmpr2, respectively downregulated and upregulated in
POST tissues), and various effectors of the pathway (including
Mapk genes acting in several pathways). While several Fgf genes
were upregulated (Table 2), Fgf8, previously shown to be
upregulated in RA-deficient embryos [8,9,10] was not picked up
by the microarray analysis, an explanation being that the shift in
the Fgf8 mRNA gradient [71] only occurs in a small region of the
Raldh22/2 embryos (the anteriormost presomitic mesoderm).
Upregulation of several Bmp genes – the highest for Bmp4 in
ANT tissues, is also noteworthy. Within the TGFb pathway there
were a majority of upregulated genes, both in ANT and POST
tissues. This is consistent with a previous study which identified the
TGFb pathway as being abnormally upregulated and involved in
the phenotypic abnormalities observed during early embryonic
lung development [70]. The Hedgehog signaling pathway
exhibited the smallest numbers of misregulated genes (6 in ANT
tissues, 4 in POST tissues), reflecting the small number of genes
(28) included in this category, and included Gli1 (previously
identified as downregulated in Raldh22/2 embryos: ref. [6]) and
Indian hedgehog (Ihh, downregulated in POST tissues).
In summary, this bioinformatic analysis confirmed that retinoic
acid deficiency affects the regulation of genes involved in a wide
range of molecular pathways. Remarkably, the main develop-
mental signaling pathways previously implicated as being retinoid-
dependent (FGF, TGFb/BMP, Hedgehog, Wnt; refs. [22,67,68]
for reviews) do not appear as the top pathways in terms of
statistical significance, hence the analysis summarized in Fig. 8
Figure 9. VENN diagrams summarizing a cross-comparison of the genes downregulated in Raldh22/2 embryos (A, anterior tissues;
B, posterior tissues) with those identified as RAR-bound by ChIP-seq analysis of embryonic stem (ES) cells differentiating as
embryoid bodies (ref. [72]), and those induced after RA treatment of embryoid bodies. This analysis distinguished early RA-responsive
genes (2 h after RA exposure: upper numbers; ref. [72]), from those identified at a later stage of differentiation (4 days post-RA treatment: lower
numbers; ref. [73]). Some selected genes are highlighted in the intersecting data sets.
doi:10.1371/journal.pone.0062274.g009
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provide new information on metabolic processes or signaling
pathways that may deserve further investigation.
Cross-comparison of in vivo (embryonic) data with
results from genomic and transcriptomic screens in
embryonic stem cells
Several recent studies have used differentiating murine ES cells
as a model for analyzing transcriptomic changes occurring after
RA treatment [72,73,74], and/or for analysis of genomic loci
bound by RARs, using large-scale chromatin immunoprecipitation
(ChIP-ChIP or ChIP-seq) techniques [72,75,76]. We decided to
perform a cross comparison of such studies, to identify which,
among the genes downregulated in Raldh22/2 embryos, may also
have been identified as being RA-inducible, or RAR-bound
according to ChIP data, in differentiating ES cells. This
comparison was performed with the data of Moutier et al., who
reported the most extensive set of RAR-bound loci, identifying
6628 RAR occupied loci in ES cells grown for 4 days as embryoid
bodies (EBs) and treated for 2 h with RA [72]. To narrow down
the cross-comparison, their genomic list was restricted to loci in
which the RAR-occupied sites were located within 65 kilobases
(Kb) from the transcription start site. These authors also
performed a comparative transcriptomic (RNA-seq) analysis of
EBs grown for 4 days and treated (or not treated) with RA,
identifying 824 RA-induced transcripts [72]. We further used the
data of Kim et al., who identified by Affymetrix array analysis
1202 gene transcripts upregulated in ES cells driven to a neural
phenotype after exposure to RA from day 4 to 8 in a 12-day
suspension culture [73]. Unekama et al. also reported transcrip-
tional signatures of EBs driven to neural differentiation, and here
we used their data set of 147 genes induced at day 8 of
differentiation, after RA treatment from day 2 to 6 [74].
Figure 9 provides an overview of this comparative analysis in
the form of Venn diagrams. An immediate major conclusion is
that there are very limited overlaps between the sets of genes
identified in this study, and those described as RA-inducible or
RAR-bound in ES cells. Indeed there were only 31 (,2.2%) of the
genes downregulated in anterior tissues, and 15 (,1.8%) of those
downregulated in posterior tissues of Raldh22/2 embryos, that
were tagged as RAR-bound by Moutier et al. [72]. Also, only 4%
of the ‘‘anteriorly-affected’’ genes, and 5.5% of the ‘‘posteriorly-
affected’’ genes appeared in the RNA-seq data of Moutier et al.,
i.e. behave as early RA-inducible genes in EBs. Additional genes
were found by comparing our data to those of Kim et al. [73] and
Akanuma et al. [74], which correspond to transcriptional signa-
tures at a later stage of neural differentiation (2–4 days after the
RA treatment). The complete gene lists are available as online
supporting information (Table S3).
Surprisingly, only a handful (2 and 3 genes, respectively) were
common to the three data sets, i.e. were RA-inducible and RAR-
bound in ES cells, and affected anteriorly or posteriorly in
Raldh22/2 embryos (Fig. 9). Whereas the anteriorly affected genes
did not obviously appear as ‘‘developmental’’ genes (Atp1b1,
ATPase, Na/K transporter b1 polypeptide; Acsl4, acyl-coA
synthetase family member 4), the retinaldehyde dehydrogenase/
reductase gene Dhrs3 [39] was one such gene affected posteriorly.
It may indeed be a key gene for feedback mechanisms regulating
retinoid levels, both in the embryo and in cell systems. The few
other genes common between our lists and the RAR-bound loci
included several interesting candidates, namely the gene encoding
fatty acid-binding protein (Fabp) 5 – identified in other cell systems
as a regulator of the anti-apoptotic and proliferative response to
RA [77]), or genes encoding the BMP receptor Bmpr1b, the cell
cycle regulator Ccar1, and zinc finger (Znfx1, Zfp428) or ring
finger (Rnf144b) proteins. Examples of genes downregulated in
Raldh22/2 embryos, and reported as early RA-responsive in ES
cells [72], are given in Fig. 9. While these include several known
RA-target genes (described above), they highlight additional genes
whose misregulation may be relevant for the RA-deficiency
phenotypes.
Analysis of cis-regulatory elements in downregulated
genes
Lastly, we used another bioinformatic approach to assess
whether the genes defined here as being RA-dependent in the
early embryo, may share other common regulatory features. We
used the oPOSSUM online resource and database (refs. [78,79];
http://opossum.cisreg.ca/oPOSSUM3/) to perform this analysis.
The oPOSSUM single site analysis (SSA) tool allows to identify
over-represented transcription factor binding sites (TFBS) in
specific sets of genes, giving scores to assess over-representation
either at the gene level, or at the TFBS occurrence level. We
interrogated the oPOSSUM database for SSA analysis on two sets
of genes, corresponding to the most severely downregulated genes
(FC ,21.5) in anterior or posterior Raldh22/2 tissues (146 and 63
genes, respectively). A summary of the retrieved data is provided in
Table 3. Interestingly, the first ranked transcription factor (highest
Z-score) for posteriorly downregulated genes is the RAR:RXR
DR5 dimer. While this result further tends to validate our
transcriptomic data, the corresponding gene hits were only 8,
which included Dhrs3, Meox1, Metrn, Rarb, and Stra6. This finding
would suggest that only a small fraction of the genes identified as
downregulated in our study, are actually direct targets of
RAR:RXR regulation.
Among other transcription factors with overrepresented binding
sites are several forkhead factors (Foxa1, Foxa2 posteriorly, Foxa1,
Foxd1, Foxd3, Foxo3 anteriorly). Binding sites for high mobility
group (SRY-related or Sox) factors were also amongst the most
overrepresented. Unlike RAR:RXR binding sites, these yielded
very high numbers of hits, both in terms of gene numbers (in all
cases .50% of the genes analyzed) and of TFBS identified (up to
782 per gene; see Table 3). This abundance probably reflects an
overinflation of putative TFBS, often encountered with bioinfor-
matic search engines, when the TFBS consensus is defined as a
relatively short and degenerate sequence. The same conclusion
was drawn for most of the homeodomain proteins identified in this
search (e.g. Nobox, NKx2.5, Pdx1 or Hoxa5, all of which
appeared with high Z-scores for both the anterior and posterior
gene sets, and yield up to .1000 TFBS hits). This clearly points to
a limitation of the search engine. However, and despite this
overinflation, we would conclude that TFBS bioinformatic analysis
will help selecting subsets of Raldh22/2 misregulated genes that
may be regulated by specific homeodomain factors. A possible,
combinatorial regulation by forkhead (Fox) and Sox proteins will
also deserve further investigation.
On the other hand, the TFBS analysis provided several clues on
regulation by specific transcription factors, with emerged with high
Z-scores on much smaller numbers of putative targets. Noteworthy
was the high Z-score of Pax5 and Pax6 for posterior genes (8 and 5
gene hits, respectively; Crabp2, Dbx1, Rarb and Stra6 appearing as
putative Pax6 targets). Regulation by Pbx1, a cofactor for Hox
genes, was also highlighted for 15 posterior genes (Table 3). These
included already documented Hox/Pbx targets such as Hoxa1 [80]
and Rarb [81], and pointed to Ccne1, Lrg5, Nepn, NKx2-9 and 3-1 or
Rfx6 as additional putative targets. A set of 8 genes was defined as
putative Brachyury (T) targets; these included Lhx1, Pmm2,
Prdm13, NKx2-9 and Stra6. Involvement of STAT1 and/or STAT3
as possible regulators of several posterior genes was highlighted.
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These included Ccne1, Crabp2, Dbx1, Dhrs3, Rarb and Stra6. Finally,
three nuclear receptors were identified through this analysis:
NR2F1 (COUP-TF I) as a putative regulator of 17 posterior genes,
the PPARc:RXRa dimer, with 22 putative targets among
posterior genes, and NR3C1 (glucocorticoid receptor) with 21
identified targets among anterior genes (details on target genes in
Table 3).
Altogether, this TFBS database search highlighted the combi-
natorial regulation of embryonic RA-dependent genes by several
families of transcriptional regulators, while providing strong
candidates for the regulation of specific subsets of genes. It also
pointed out to four genes of the RA pathway: Dhrs3, Crabp2, Rarb,
and Stra6, as key targets for such combinatorial regulation.
Conclusion
This study provides an overview of the genes misregulated in
early mouse embryos unable to synthesize retinoic acid (RA) from
its precursor retinaldehyde, due to targeted gene disruption of a
critical biosynthesis enzyme. While highlighting several genes
known to be affected by conditions of impaired RA signaling in
mouse embryos and/or other animal models, it provides
additional candidate genes and pathways that may be relevant
to better understand the mechanisms underlying the complex
Table 3. Bioinformatic analysis of putative transcription factor binding sites (oPOSSUM3 single site analysis method) in genes
showing the highest downregulation in posterior or anterior tissues of Raldh22/2 embryos.
Transcription factor (c) Family
Gene
hits
TFBS
hits Z-score
Transcription
factor (c) Family
Gene
hits
TFBS
hits Z-score
RXR:RAR (DR5) (d) Nuclear receptor 8 11 11.40 Nobox Homeodomain 107 679 21.90
MZF1_5-13 bba zinc finger 43 272 10.27 NKx2-5 Homeodomain 124 1566 19.22
Nobox Homeodomain 48 262 9.90 Pdx1 Homeodomain 120 1115 17.73
Foxa1 Forkhead 40 222 8.14 Hoxa5 Homeodomain 123 1574 15.15
Foxa2 Forkhead 40 152 7.84 REST (l) bba zinc finger 6 6 14.66
Pax5 (e) Paired domain 8 8 7.78 Prrx2 Homeodomain 109 938 13.98
SRY HMG group 48 328 6.87 Sox9 HMG group 88 379 12.99
NKx2-5 Homeodomain 52 606 6.86 SRY HMG group 112 782 10.28
HNF1B Homeodomain 17 27 6.58 Sox17 HMG group 109 558 10.16
ARID3A Arid 48 494 6.08 NFYA NFY CCAAT binding 51 91 10.02
NR2F1 (f) (COUP-TF I) Nuclear receptor 17 23 5.74 Sox5 HMG group 99 554 8.86
STAT1 (g) Stat 19 40 5.49 Foxd1 Forkhead 93 496 7.78
HNF1A Homeodomain 14 16 5.36 NKx3-1 Homeodomain 103 530 6.63
Pdx1 Homeodomain 49 418 5.35 Foxd3 Forkhead 85 340 5.86
PBX1 (h) Homeodomain 15 25 5.21 Pou5f1 (Oct4) (m) Homeodomain 26 40 5.81
PPARG:RXRA (i) Nuclear receptor 22 40 3.96 Lhx3 Homeodomain 41 88 5.56
Hoxa5 Homeodomain 52 607 3.70 Foxo3 Forkhead 95 537 5.47
T (Brachyury) (j) b-ribbon 8 10 3.63 NR3C1 (GR) (n) Nuclear receptor 21 28 5.12
STAT3 Stat 32 82 3.48 HNF1B Homeodomain 33 54 4.70
Pax6 (k) Paired domain 5 6 3.26 Foxa2 Forkhead 82 323 3.97
(a)59 genes analyzed from 63 genes downregulated with FC ,21.5.
(b)137 genes analyzed from 146 genes downregulated with FC ,21.5.
(c)The searched region encompassed 5 Kb upstream and 5 Kb downstream of the transcription start site. The top ten factors (highest Z-scores) appear in bold. Additional
transcription factors (below) are the authors’ seelection.
(d)Genes with conserved RAR:RXR (DR5) binding sites are: Csn3, Dhrs3, Fap, Meox1, Metrn, Rarb, Stra6, 5730596B20Rik (NB: 5730596B20Rik is an antisense EST found
between the Hoxa3 and Hoxa4 genes).
(e)Genes with conserved Pax5 binding sites are: Apba2, Crabp2, Lgr5, Mettl1, NKx2-9, Pmm2, Ripply3, Rfx6.
(f)Genes with conserved NR2F1 binding sites are: Apba2, Crabp2, Dhrs3, Dusp9, Fap, Gcsh, Hoxa1, Maob, NKx2-9, Pax6, Prdm13, Rarb, Sfrp5, Stra6, Timm8a1, Tmem56,
1700011H14Rik.
(g)Genes with conserved STAT1 binding sites are: Apba2, Dbx1, Dhrs3, Fap, Hoxa1, Gcsh, Kynu, Lgr5, Meox1, Pax6, Prdm13, Ptprz1, Rarb, Ripply3, Slc25a10, Snora34, Stra6,
Timm8a1, 5730596B20Rik.
(h)Genes with conserved PBX1 binding sites are: Ccne1, Dbx1, Fap, Hoxa1, Kynu, Lgr5, Nepn, Nkx2-9, Nkx3-1, Pax6, Prdm13, Rarb, Rfx6, Ripply3, Tmem56.
(i)Genes with conserved PPARG:RXRA binding sites are: Apba2, Cpn1, Crabp2, Dbx1, Dhrs3, Dusp9, Gcsh, Hoxa1, Lhx1, Meox1, Mtap7d2, Nkx3-1, Pax6, Prdm13, Ptprz1, Rarb,
Sh3bgrl2, Snord118, Stra6, Trmt61a, 1700011H14Rik, 5730596B20Rik.
(j)Genes with conserved T binding sites are: Lhx1, NKx2-9, Pmm2, Prdm13, Stra6, Timm8a1, Trmt61a, 5730596B20Rik.
(k)Genes with conserved Pax6 binding sites are: Dbx1, Pax6, Rarb, Stra6, 5730596B20Rik.
(l)Genes with conserved REST binding sites are: Acsl6, Ank1, Cntnap2, Lhx2, Mpped1.
(m)Genes with conserved Pou5fI binding sites are: Abcb10, Acsl6, Ank1, Apba2, Arrdc4, Aven, Cdh20, Cntnap2, Dhrs11, Gas5, Htr3b, Ikzf1, Lhx2, Mrpl18, Muc1, Neto2, Nova1,
Nr2e1, Pak3, Pcdh19, Prdm16, Rragb, Shox2, Slc25a21, Taf1d, Wnt7a.
(n)Genes with conserved NR3C1 binding sites are: Cntnap2, Eef1d, Fez1, Hsd17b7, Htr3b, Itgb8, Klf1, Lrcc4, Lhx2, Mpped1, Mrpl20, Nova1, Nsdhl, Pcdh19, Pdss1, Phyhipl,
Pou3f3, Rnf144b, Shox2, Syt11, AI504432.
Transcription factor binding site (TFBS) analysis: genes downregulated in POSTERIOR tissues.(a)
TFBS analysis: genes downregulated in ANTERIOR tissues.(b)
doi:10.1371/journal.pone.0062274.t003
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phenotypic consequences of embryonic RA deficiency. Bioinfor-
matic analysis confirmed the impact of retinoid deficiency on
several signaling pathways, with specific genes misregulated and
belonging to the FGF, Notch, BMP, Hedgehog, VEGF, or Wnt
pathways. This analysis pointed out to additional pathways or
biological functions which, although not previously correlated with
retinoid deficiency, appeared in the top (most significant)
categories. This provides clues for further exploration of the effect
of retinoid deficiency on metabolic processes such as purine and
pyrimidine metabolism or one carbon metabolism, on signaling
pathways such as the mTOR, ILK and IGF1 pathways, or on
protein ubiquitination. Our data also suggest an upregulation of
calcium signaling, specific to posterior (trunk) tissues of RA-
deficient embryos.
This study adds to a framework of other high-throughput
studies that reported RA-dependent transcriptomic alterations
[72,73,74,82], or characterization of RAR target gene loci
[72,75,76,82], in tissue culture cells including embryonic stem
cells. Remarkably, a cross comparison between several data sets
revealed that only a small subset of genes downregulated in
Raldh22/2 embryos were previously identified as RAR-bound, or
RA-inducible, in embryonic stem cells. Future high-throughput
genomic/transcriptomic studies, expected to be performed on
other retinoid target tissues, should improve our knowledge on
retinoid-dependent gene regulation, both during normal develop-
mental and physiological processes, and with respect to various
diseases including cancer.
Materials and Methods
Ethics statement, mouse lines and embryonic tissue
collection
Animal experimentation protocols were reviewed and approved
by the Direction De´partementale des Services Ve´te´rinaires
(agreement # 67–189 dated March 30, 2009) and conformed to
the NIH and European Union guidelines, provisions of the Guide
for the Care and Use of Laboratory Animals, and the Animal
Welfare Act. No invasive (pain-inducing) procedure was used for
this study. The mice harbored the Raldh2 knockout allele described
in ref. [26] and, for the X-gal assays, the RARE-hsp68-lacZ
transgene described in ref. [32]. Pregnant female mice were
euthanized after anesthesia with CO2, embryos were collected and
tissue samples were quickly dissected, by sectioning with fine
tweezers and freezing in liquid nitrogen. Extra-embryonic
membranes were used for genotyping of the embryos.
Microarray hybridization and bioinformatic analysis
Total RNA was extracted with the RNAeasy micro Kit (Qiagen)
from individual embryonic samples. RNA quality was verified by
analysis on a 2100 Bioanalyzer (Agilent), and only samples
displaying a RNA Integrity Number (RIN) greater than 9.0 were
selected for analysis. Biotinylated single strand cDNA targets were
prepared, starting from 300 ng RNA, using the Ambion WT
Expression Kit (Cat #4411974) and the Affymetrix GeneChip
WT Terminal Labeling Kit (Cat #900671), according to
Affymetrix recommendations. For each sample, 1.9 mg cDNA
was hybridized for 16 h at 45uC on GeneChip Mouse Gene 1.0
ST arrays, containing 35556 probe sets interrogating over 28000
genes represented by 27 probes (25-mer) spread across the full
length of the gene. The chips were washed and stained in the
GeneChip Fluidics Station 450 (Affymetrix), and scanned with the
GeneChip Scanner 3000 7G (Affymetrix). Finally, raw data (.CEL
Intensity files) were extracted from the scanned images using the
Affymetrix GeneChip Command Console (AGCC) version 3.1.
CEL files were further processed with the Partek genomics suite
6.5 software to obtain principal component analysis (PCA), in
order to verify the sample distribution. Genes considered as
differentially expressed had a hybridization signal value above 5
(20th percentile of all expression values) in at least one sample.
Differential expression was considered significant if the false
discovery rate from Benjamini and Hochberg test was under 10%,
corresponding to a p-value #0.05 for the ANT data set and#0.03
for the POST data set, determined by student t-test. Selected lists
for the ANT and the POST data sets were analyzed with the
Ingenuity pathway analysis (http://www.Ingenuity.com) software.
The array CEL files were submitted to the NIH Gene Expression
Omnibus (GEO) database (accession number GEO: GSE43578).
Real-time quantitative RT-PCR
RT-PCR assays were performed in triplicate on three indepen-
dent RNA samples for each tissue type and genotype. RNA
extractions were performed as previously described. Oligo-dT
primed cDNAs were generated using the Superscript II kit
(Invitrogen) according to the manufacturer’s protocol with.
Quantitative real-time PCR was achieved using SybrGreen and
LightCycler 480 (Roche). The sequences of primers used for the
various tested genes are given in Table S4 (online supporting
information). Probe sets for detection of mouse Gapdh (glyceralde-
hyde-3-phosphate dehydrogenase) and Actb (beta-actin) were used
for normalization. For each sample the ratio between signals for
the gene of interest and Gapdh was calculated to normalize
concentration values. To verify if genes were differentially
expressed, the average of ratios calculated for wild-type and
mutant samples were then compared.
In situ hybridization and X-gal staining
Whole-mount in situ hybridization with digoxigenin-labeled
riboprobes was performed as described [83], using an Intavis
InSituPro robot (for details, see http://www.empress.har.mrc.ac.
uk/browser/, Gene Expression section). X-gal assays were
performed as described [32].
Supporting Information
Figure S1 Hierarchical clustering of differentially ex-
pressed genes. The heatmap shows the gene expression profiles
of microarray data sets (upregulated expression: red; downregu-
lated expression: green). Importantly, the WT and KO samples
segregate into fully distinct clusters according to this analysis.
ANT: RNA from anterior tissues; POST: RNA from posterior
tissues; WT: wild-type embryos; KO: Raldh22/2 embryos.
(TIF)
Table S1 Genes exhibiting a ‘‘contradictory’’ behavior
in the microarray experiments, i.e. downregulated in
one type of tissue samples and upregulated in the other
(±1.2 fold change) in Raldh22/2 embryos.
(DOC)
Table S2 Genes involved in the process of transcrip-
tion/transcriptional regulation and downregulated in
Raldh22/2 embryos. Genes are listed separately for the ANT
and POST microarray experiments. Genes with ,21.5 fold
changes appear in bold.
(PDF)
Table S3 Genes found in common in our transcriptomic
study (genes downregulated in anterior or posterior
tissues of Raldh22/2 embryos), and in studies which
identified RA-inducible genes by RNA-seq (ref. [72]) or
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microarray (refs. [73,74]) analysis of differentiating ES
cells. A cross-comparison with genes reported as RAR-bound in
differentiating ES cells (ref. [72]) was also performed.
(PDF)
Table S4 Sequences of primers used in the quantitative
RT-PCR experiments (F: forward primer; R: reverse
primer).
(PDF)
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